Author

Shannon Deluca

Observed names: S. DeLuca, Shannon DeLuca

Institution: University of Pennsylvania

Observed institution: University of Pennsylvania

OpenAlex ID: A5043653142

Targeting dormant tumor cells to prevent recurrent breast cancer: a randomized phase 2 trial

2025 · Angela DeMichele, Amy S. Clark, et al. · Nature Medicine · 44

Abstract PD9-11: Identifying breast cancer survivors with dormant disseminated tumor cells: The PENN-SURMOUNT screening study

2021 · Lauren Bayne, Isoris Nivar, et al. · Cancer Research · 8

Outcomes and clinicopathologic characteristics associated with disseminated tumor cells in bone marrow after neoadjuvant chemotherapy in high-risk early stage breast cancer: the I-SPY SURMOUNT study

2023 · Mark Jesus M. Magbanua, Laura van ‘t Veer, et al. · Breast Cancer Research and Treatment · 7

Abstract PS9-03: Circulating tumor DNA (ctDNA), dormant disseminated tumor cells (DTCs) and recurrence outcomes in breast cancer survivors on the SURMOUNT Study

2025 · Eleanor Taranto, Nicholas J. Seewald, et al. · Clinical Cancer Research · 2

Abstract PD5-02: 5-year outcomes and ctdna findings in the clever trial targeting disseminated dormant tumor cells

2026 · A. DeMichele, L. Bayne, et al. · Clinical Cancer Research · 1

DTC-Flow: a flow cytometry-based detection platform for characterizing bone marrow disseminated tumor cells in breast cancer

2025 · Elizabeth M. Chislock, Tien-chi Pan, et al. · npj Breast Cancer · 1

Abstract PD9-10: Investigating the clinical utility of tumor mutational burden in predicting rapid progression and death in patients with metastatic breast cancer

2021 · Igor Makhlin, Amy S Clark, et al. · Cancer Research · 1

Abstract PS2-07: Outcomes associated with disseminated tumor cells at surgery after neoadjuvant chemotherapy in high-risk early stage breast cancer: The I-SPY SURMOUNT study

2021 · Mark Jesus M Magbanua, Laura van 't Veer, et al. · Cancer Research

Works count: 8

Citation count: 63

H-index: 3

I10-index: 1